期刊
PHYTOTHERAPY RESEARCH
卷 35, 期 9, 页码 4834-4897出版社
WILEY
DOI: 10.1002/ptr.7119
关键词
analogue; curcumin; delivery system; gastrointestinal cancers
Gastrointestinal (GI) cancers have a high global prevalence and are a leading cause of morbidity and mortality. Curcumin, a naturally occurring compound with documented safety and anticancer activities, shows promise in the treatment of GI cancers but is limited by its low solubility and chemical stability in water. Strategies such as using analogues or novel delivery systems may help overcome these limitations for more effective clinical applications.
Gastrointestinal (GI) cancers with a high global prevalence are a leading cause of morbidity and mortality. Accordingly, there is a great need to develop efficient therapeutic approaches. Curcumin, a naturally occurring agent, is a promising compound with documented safety and anticancer activities. Recent studies have demonstrated the activity of curcumin in the prevention and treatment of different cancers. According to systematic studies on curcumin use in various diseases, it can be particularly effective in GI cancers because of its high bioavailability in the gastrointestinal tract. Nevertheless, the clinical applications of curcumin are largely limited because of its low solubility and low chemical stability in water. These limitations may be addressed by the use of relevant analogues or novel delivery systems. Herein, we summarize the pharmacological effects of curcumin against GI cancers. Moreover, we highlight the application of curcumin's analogues and novel delivery systems in the treatment of GI cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据